Abstract
Stroke is one of the disorders for which clinically effective therapeutic modalities are most needed, and numerous ways have been explored to attempt to investigate their feasibilities. However, ischemic- or hemorrhagicinduced inflammatory neuron death causes irreversible injuries and infarction regions, and there are currently no truly effective drugs available as therapy. It is therefore urgent to be able to provide a fundamental treatment method to regenerate neuronal brain cells, and therefore, the use of stem cells for curing chronic stroke could be a major breakthrough development. In this review, we describe the features and classification of stroke and focus on the benefits of adipose tissue-derived stem cells and their applications in stroke animal models. The results show that cell-based therapies have resulted in significant improvements in neuronal behaviors and functions through different molecular mechanisms, and no safety problems have so far arisen after transplantation. Further, we propose a clinical possibility to create a homing niche by reducing the degree of invasive intracerebroventricular transplantation and combining it with continuous intravenous administration to achieve a complete cure. © 2014 Cognizant Comm. Corp.
Author supplied keywords
Cite
CITATION STYLE
Chan, T. M., Harn, H. J., Lin, H. P., Chiu, S. C., Lin, P. C., Wang, H. I., … Lin, S. Z. (2014). The use of ADSCs as a treatment for chronic stroke. Cell Transplantation. Cognizant Communication Corporation. https://doi.org/10.3727/096368914X678409
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.